Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moluodan for chronic atrophic gastritis
ChiCTR1800016087Phase 4Completed
- Sponsor
- Renji Hospital
- Start
- Oct 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of moluodan and folic acid in atrophic gastritis (AG) (4 arms), sponsored by Renji Hospital. Primary endpoint: Biopsy pathology results. Started Oct 2017; status: completed.
02
Drugs
moluodanfolic acid
03
Conditions
atrophic gastritis (AG)
Beyond the preview
Go deeper on ChiCTR1800016087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016087.